Carregant...
Community perspective on the INSIGHT Strategic Timing of AntiRetroviral Treatment trial
Determining when to start antiretroviral treatment (ART) is vitally important for people living with HIV. Yet the optimal point to start to maximise clinical benefit remains unknown. In the absence of randomised studies, current guidelines rely on conflicting observational data and expert opinion, a...
Guardat en:
| Publicat a: | HIV Med |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4341942/ https://ncbi.nlm.nih.gov/pubmed/25711318 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/hiv.12228 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|